Therapeutic trials with tobramycin.
作者信息
Valdivieso M, Horikoshi N, Rodriguez V, Bodey G P
出版信息
Am J Med Sci. 1974 Sep;268(3):149-56. doi: 10.1097/00000441-197409000-00003.
Abstract
摘要
相似文献
1
Therapeutic trials with tobramycin.妥布霉素的治疗试验。
Am J Med Sci. 1974 Sep;268(3):149-56. doi: 10.1097/00000441-197409000-00003.
2
Carbenicillin therapy of gram-negative bacilli infections.羧苄青霉素治疗革兰氏阴性杆菌感染。
Am J Med Sci. 1969 Jun;257(6):408-14. doi: 10.1097/00000441-196906000-00007.
3
Tobramycin: clinical and microbiological evaluation.妥布霉素：临床与微生物学评估。
Int J Clin Pharmacol. 1973 Nov;8(3):207-15.
4
Clinical and laboratory studies with tobramycin.妥布霉素的临床与实验室研究。
Chemotherapy. 1974;20(4):245-56. doi: 10.1159/000221814.
5
[Aminoglycoside antibiotics from clinical viewpoint].[从临床角度看氨基糖苷类抗生素]
Int J Clin Pharmacol Biopharm. 1975 Mar;11(2):112-25.
6
[Antibiotic cover during antineoplastic therapy].[抗肿瘤治疗期间的抗生素覆盖]
Minerva Med. 1973 Apr 25;64(27):1438-41.
7
Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rods.用羧苄青霉素和庆大霉素治疗癌症患者以及由革兰氏阴性杆菌引起的严重感染。
Cancer. 1973 Feb;31(2):331-6. doi: 10.1002/1097-0142(197302)31:2<331::aid-cncr2820310210>3.0.co;2-s.
8
Carbenicillin: clinical and laboratory experience with a parenterally administered penicillin for treatment of Pseudomonas infections.羧苄青霉素：一种用于治疗假单胞菌感染的胃肠外给药青霉素的临床及实验室经验。
Ann Intern Med. 1969 Nov;71(5):903-11. doi: 10.7326/0003-4819-71-5-903.
9
Piperacillin treatment of urinary infections.哌拉西林治疗泌尿系统感染
Med J Aust. 1981 Jan 10;1(1):35-6. doi: 10.5694/j.1326-5377.1981.tb135287.x.
10
Temocillin in the treatment of serious gram-negative infections.替莫西林治疗严重革兰氏阴性菌感染
Drugs. 1985;29 Suppl 5:191-3. doi: 10.2165/00003495-198500295-00041.
引用本文的文献
1
The role of schedule of antibiotic therapy on the neutropenic patient.抗生素治疗方案在中性粒细胞减少患者中的作用。
Infection. 1980;Suppl 1:75-81. doi: 10.1007/BF01644940.
2
Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patients.哌拉西林联合万古霉素治疗癌症患者发热性疾病
Antimicrob Agents Chemother. 1984 Sep;26(3):295-9. doi: 10.1128/AAC.26.3.295.
3
Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients.美洛西林作为发热性粒细胞缺乏癌症患者经验性单药治疗的潜力。
Antimicrob Agents Chemother. 1980 Aug;18(2):299-306. doi: 10.1128/AAC.18.2.299.
4
Mezlocillin for treatment of infections in cancer patients.美洛西林用于治疗癌症患者的感染。
Antimicrob Agents Chemother. 1980 Jun;17(6):1008-13. doi: 10.1128/AAC.17.6.1008.
5
A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients.头孢他啶与头孢他啶加氟氯西林在严重中性粒细胞减少患者发热性发作经验性治疗中的随机前瞻性研究。
Antimicrob Agents Chemother. 1985 Dec;28(6):824-8. doi: 10.1128/AAC.28.6.824.
6
Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.发热性中性粒细胞减少癌症患者的经验性抗生素治疗：单一疗法的临床疗效及影响
Antimicrob Agents Chemother. 1987 Jul;31(7):971-7. doi: 10.1128/AAC.31.7.971.
7
Review of Citrobacter bacteremia in cancer patients over a sixteen-year period.16年期间癌症患者柠檬酸杆菌血症的回顾。
Eur J Clin Microbiol Infect Dis. 1991 Jun;10(6):479-85. doi: 10.1007/BF01963933.
8
The use of tombramycin in the management of severe infections. Clinical and pharmacological data.托姆布拉霉素在严重感染治疗中的应用。临床及药理学数据。
Eur J Intensive Care Med. 1976 Sep;2(2):89-96. doi: 10.1007/BF01886122.
9
Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.妥布霉素：抗菌及药代动力学特性与治疗用途综述
Drugs. 1976;12(3):166-200. doi: 10.2165/00003495-197612030-00002.
10
Clinical and laboratory study of tobramycin in the treatment of infections due to gram-negative organisms.妥布霉素治疗革兰氏阴性菌感染的临床及实验室研究
Can Med Assoc J. 1977 Jul 23;117(2):138-43.
Zotero 插件